MedTrace Logo

The Effect of a Drama-Based Coloring Storybook on Children's Fear, Anxiety, and Pain Management in the Perioperative Process: "Alican's Brave Journey"

NCT07414628 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2026-02-17

No results posted yet for this study

Summary

This randomized controlled study aims to evaluate the effect of a drama-based coloring storybook on children's fear, anxiety, and pain management during the perioperative process. The study will be conducted with children aged 6-9 years who are scheduled for elective surgery. Participants will be randomly assigned to either an intervention group receiving the drama-based coloring storybook or a control group receiving routine preoperative care. Levels of fear, anxiety, and pain will be assessed using validated measurement tools at predefined perioperative time points. The findings are expected to contribute to evidence-based, child-centered perioperative care practices.

Conditions

  • Preoperative Anxiety
  • PAİN
  • Fear

Interventions

BEHAVIORAL

Drama-Based Coloring Storybook Intervention

Children aged 6-9 years in the experimental group receive a drama-based coloring storybook before surgery. The storybook, titled "Alican's Brave Journey," is designed to prepare children for the perioperative process through age-appropriate storytelling, coloring activities, and dramatic elements. The intervention is administered once during the preoperative period under the supervision of the researcher and aims to reduce preoperative fear, anxiety, and perceived pain.

Sponsors & Collaborators

  • Ataturk University

    collaborator OTHER

  • Bingol University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
9 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-01
Primary Completion
2026-12-15
Completion
2026-12-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07414628 on ClinicalTrials.gov